Regulation of macrophage activation

Cellular and Molecular Life Sciences

Volumn 60, Issue 11, 2003, Pages 2334-2346

  Ma, J ^a   Chen, T ^b   Mandelin, J ^a   Ceponis, A ^c   Miller, N E ^d   Hukkanen, M ^a   Ma, G F ^a   Konttinen, Y T ^b,e,f  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d Omni Viz Inc   (United States)

^e ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^f BIOMEDICUM HELSINKI   (Finland)

Author keywords

Alternate activation; Classical activation; Deactivation; Macrophage; Priming

Indexed keywords

ADRENALIN; ANDROSTANOLONE; ANTIGEN; CALCITRIOL; CORTICOSTEROID; CORTICOTROPIN; CYTOKINE; ESTRADIOL; ESTROGEN; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NORADRENALIN; PARATHYROID HORMONE; PROGESTERONE; PROSTAGLANDIN E2; TESTOSTERONE; TUMOR NECROSIS FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIGEN PRESENTATION; APOPTOSIS; DNA MICROARRAY; ENDOCYTOSIS; GENE CONTROL; GRANULOMA; HELPER CELL; HUMAN; MACROPHAGE ACTIVATION; MAST CELL; NONHUMAN; REVIEW; UPREGULATION;

ANIMALS; APOPTOSIS; CYTOKINES; FOREIGN BODIES; HORMONES; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; TH1 CELLS; TH2 CELLS; TOLL-LIKE RECEPTORS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0344393516     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3020-0     Document Type: Review

References (81)

1. Xaus J., Comalada M., Valledor A. F., Cardo M., Herrero C., Soler C. et al. (2001) Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 204: 543-550
2. Gordon S. (2002) Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927-930
3. DeFife K. M., Jenney C. R., Colton E. and Anderson J. M. (1999) Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion. J. Histochem. Cytochem. 47: 65-74
4. Pu Z., Carrero J. A. and Unanue E. R. (2002) Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc. Natl. Acad. Sci. USA 99: 8844-8849
5. Domeika K., Berg M., Eloranta M. L. and Alm G. V. (2002) Porcine interleukin-12 fusion protein and interleukin-18 in combination induce interferon-gamma production in porcine natural killer and T cells. Vet. Immunol. Immunopathol. 86: 11-21
6. Bellinghausen I., Brand P., Bottcher I., Klostermann B., Knop J. and Saloga J. (2003) Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6. Immunology 108: 167-176
7. Oswald I. P., Gazzinelli R. T., Sher A. and James S. L. (1992) IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148: 3578-3582
8. Petrova T. V., Akama K. T. and Van Eldik L. J. (1999) Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2. Proc. Natl. Acad. Sci. USA 96: 4668-4673
9. Verbovetski I., Bychkov H., Trahtemberg U., Shapira I., Hareuveni M., Ben-Tal O. et al. (2002) Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86 and up-regulates CC chemokine receptor 7. J. Exp. Med. 196: 1553-1561
10. Moodley Y., Rigby P., Bundell C., Bunt S., Hayashi H., Misso N. et al. (2003) Macrophage recognition and phagocytosis of apoptotic fibroblasts Is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am. J. Pathol. 162: 771-779
11. Demarchi F., Verardo R., Varnum B., Brancolini C. and Schneider C. (2001) Gas6 anti-apoptotic signaling requires NF-kappa B activation. J. Biol. Chem. 276: 31738-31744
12. Meldrum D. R., Cleveland J. C. Jr, Moore E. E., Partrick D. A., Banerjee A. and Harken A. H. (1997) Adaptive and maladaptive mechanisms of cellular priming. Ann. Surg. 226: 587-598
13. Randal M. and Kossiakoff A. A. (2001) The structure and activity of a monomeric interferon-gamma:alpha-chain receptor signaling complex. Structure (Camb) 9: 155-163
14. Decker T., Kovarik P. and Meinke A. (1997) GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17: 121-134
15. Battistini A., Marsili G., Sgarbanti M., Ensoli B. and Hiscott J. (2002) IRF regulation of HIV-1 long terminal repeat activity. J. Interferon Cytokine Res. 22: 27-37
16. Tschopp J., Martinon F. and Hofmann K. (1999) Apoptosis: silencing the death receptors. Curr. Biol. 9: R381-384
17. Wajant H. and Scheurich P. (2001) Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling. Int. J. Biochem. Cell Biol. 33: 19-32
18. He K. L. and Ting A. T. (2002) A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol. Cell. Biol. 22: 6034-6045
19. Brown K. D., Hostager B. S. and Bishop G. A. (2002) Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277: 19433-19438
20. Juo P., Kuo C. J., Yuan J. and Blenis J. (1998) Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr. Biol. 8: 1001-1008
21. Meylan E., Martinon F., Thome M., Gschwendt M. and Tschopp J. (2002) RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis. EMBO Rep. 3: 1201-1208
22. Hellman C., Lonnkvist K., Hedlin G., Hallden G. and Lundahl J. (2002) Down-regulated IL-5 receptor expression on peripheral blood eosinophils from budesonide-treated children with asthma. Allergy 57: 323-328
23. Pollock K. G., Conacher M., Wei X. Q., Alexander J. and Brewer J. M. (2003) Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 108: 137-143
24. Gordon S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3: 23-35
25. Hesse M., Modolell M., La Flamme A. C., Schito M., Fuentes J. M., Cheever A. W. et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167: 6533-6544
26. Berrebi D., Bruscoli S., Cohen N., Foussat A., Migliorati G., Bouchet-Delbos L. et al. (2003) Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101: 729-738
27. Lawrence T., Willoughby D. A. and Gilroy D. W. (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2: 787-795
28. Salvemini D., Misko T. P., Masferrer J. L., Seibert K., Currie M. G. and Needleman P. (1993) Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90: 7240-7244
29. Landino L. M., Crews B. C., Timmons M. D., Morrow J. D. and Marnett L. J. (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc. Natl. Acad. Sci. USA 93: 15069-15074
30. Delgado M., Abad C., Martinez C., Leceta J. and Gomariz R. P. (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7: 563-568
31. Ganea D. and Delgado M. (2001) Inhibitory neuropeptide receptors on macrophages. Microbes Infect. 3: 141-147
32. Konttinen Y. T., Kemppinen P., Segerberg M., Hukkanen M., Rees R., Santavirta S. et al. (1994) Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 37: 965-982
33. Bucland J. (2001) Macrophages: bacterial defense. 1: 173
34. Underhill D. M. and Ozinsky A. (2002) Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20: 825-852
35. Sutterwala F. S., Noel G. J., Clynes R. and Mosser D. M. (1997) Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185: 1977-1985
36. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I. and Matikainen S. (1999) Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J. Immunol. 162: 7322-7329
37. Santavirta S., Konttinen Y. T., Bergroth V., Eskola A., Tallroth K. and Lindholm T. S. (1990) Aggressive granulomatous lesions associated with hip arthroplasty. Immunopathological studies. J. Bone Joint Surg. Am. 72: 252-258
38. Austad E. D. (2002) Breast implant-related silicone granulomas: the literature and the litigation. Plast. Reconstr. Surg. 109: 1724-1730; discussion 1731-1732
39. Becker S., Fenton M. J. and Soukup J. M. (2002) Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Am. J. Respir. Cell Mol. Biol. 27: 611-618
40. Nakashima Y., Sun D. H., Trindade M. C., Maloney W. J., Goodman S. B., Schurman D. J. et al. (1999) Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J. Bone Joint Surg. Am. 81: 603-615
41. Lassus J., Salo J., Jiranek W. A., Santavirta S., Nevalainen J., Matucci-Cerinic M. et al. (1998) Macrophage activation results in bone resorption. Clin. Orthop. (352): 7-15
42. Granchi D., Ciapetti G., Stea S., Savarino L., Filippini F., Sudanese A. et al. (1999) Cytokine release in mono nuclear cells of patients with Co-Cr hip prosthesis. Biomaterials 20: 1079-1086
43. Konttinen Y. T., Xu J. W., Patiala H., Imai S., Wans V., Li T. F. et al. Cytokines in aseptic loosening of total hip replacement. Curr. Orthop. 11: 40-47
44. Petit A., Catelas I., Antoniou J., Zukor D. J. and Huk O. L. (2002) Differential apoptotic response of J774 macrophages to alumina and ultra-high-molecular-weight polyethylene particles. J. Orthop. Res. 20: 9-15
45. Chambers J., Angulo A., Amaratunga D., Guo H., Jiang Y., Wan J. S. et al. (1999) DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73: 5757-5766
46. Salunga R. C., Guo H., Luo L., Bittner A., Joy K. C., Chambers J. et al. (1999) Gene expression analysis via cDNA microarrays of laser capture microdissected cells from fixed tissue. In: DNA Microarrays, A Practical Approach, Schena M. (ed.), Oxford University Press, Oxford
47. Benjamini Y., Drai D., Elmer G., Kafkafi N. and Golani I. (2001) Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125: 279-284
48. van Rooijen N. and Sanders A. (1997) Elimination, blocking and activation of macrophages: three of a kind? J. Leukoc. Biol. 62: 702-709
49. Magez S., Stijlemans B., Radwanska M., Pays E., Ferguson M. A. and De Baetselier P. (1998) The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160: 1949-1956
50. Konttinen Y. T., Takagi M., Mandelin J., Lassus J., Salo J., Ainola M. et al. (2001) Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. J. Bone Miner. Res. 16: 1780-1786
51. Miller L. and Hunt J. S. (1996) Sex steroid hormones and macrophage function. Life Sci. 59: 1-14
52. McNally A. K. and Anderson J. M. (2002) Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am. J. Pathol. 160: 621-630
53. Vignery A. (2000) Osteoclasts and giant cells: macrophage-macrophage fusion mechanism. Int. J. Exp. Pathol. 81: 291-304
54. Schlondorff J. and Blobel C. P. (1999) Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell. Sci. 112 (Pt 21): 3603-3617
55. Choi S. J., Han J. H. and Roodman G. D. (2001) ADAM8: a novel osteoclast stimulating factor. J. Bone Miner. Res. 16: 814-822
56. Fox S. W., Fuller K., Bayley K. E., Lean J. M. and Chambers T. J. (2000) TGF-beta 1 and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype. J. Immunol. 165: 4957-4963
57. Boissy P., Destaing O. and Jurdic P. (2001) RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons. Biochem. Biophys. Res. Commun. 288: 340-346
58. Lammas D. A., De Heer E., Edgar J. D., Novelli V., Ben-Smith A., Baretto R. et al. (2002) Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int. J. Exp. Pathol. 83: 1-20
59. Qiu B., Frait K. A., Reich F., Komuniecki E. and Chensue S. W. (2001) Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am. J. Pathol. 158: 1503-1515
60. Munder M., Mallo M., Eichmann K. and Modolell M. (1998) Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187: 2103-2108
61. Golab J., Zagozdzon, Stoklosal T., Kaminski R., Kozar K. and Jakobisiak M. (2000) Direct stimulation of macrophages by IL-12 and IL-18 - a bridge too far? Immunol. Lett. 72: 153-157
62. Gessani S. and Belardelli F. (1998) IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev. 9: 117-123
63. Thomassen M. J. and Kavuru M. S. (2001) Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int. Immunopharmacol. 1: 1479-1490
64. Dalton D. K., Pitts-Meek S., Keshav S., Figari I. S., Bradley A. and Stewart T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742
65. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R. et al. (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745
66. Muller U., Steinhoff U., Reis L. F., Hemmi S., Pavlovic J., Zinkernagel R. M. et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921
67. Fiorentino D. F., Bond M. W. and Mosmann T. R. (1989) Two types of mouse T helper cell. IV Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170: 2081-2095
68. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M. G., te Velde A., Figdor C. et al. (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924
69. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W. et al. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146: 3444-3451
70. McCartney-Francis N. L. and Wahl S. M. (1994) Transforming growth factor beta: a matter of life and death. J. Leukoc. Biol. 55: 401-409
71. Kiener P. A., Moran-Davis P., Rankin B. M., Wahl A. F., Aruffo A. and Hollenbaugh D. (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155: 4917-4925
72. Shu U., Kiniwa M., Wu C. Y., Maliszewski C., Vezzio N., Hakimi J. et al. (1995) Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25: 1125-1128
73. Stout R. D., Suttles J., Xu J., Grewal I. S. and Flavell R. A. (1996) Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156: 8-11
74. Hyka N., Dayer J. M., Modoux C., Kohno T., Edwards C. K. 3rd, Roux-Lombard P. et al. (2001) Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97: 2381-2389
75. Cutolo M., Accardo S., Villaggio B., Clerico P., Indiveri F., Carruba G. et al. (1992) Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum. 35: 1007-1015
76. Morishita M., Miyagi M. and Iwamoto Y. (1999) Effects of sex hormones on production of interleukin-1 by human peripheral monocytes. J. Periodontol. 70: 757-760
77. Polan M. L., Loukides J., Nelson P., Carding S., Diamond M., Walsh A. et al. (1989) Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J. Clin. Endocrinol. Metab. 69: 1200-1206
78. Ralston S. H., Russell R. G. and Gowen M. (1990) Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res. 5: 983-988
79. Pfeilschifter J., Koditz R., Pfohl M. and Schatz H. (2002) Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23: 90-119
80. Sunyer T., Lewis J., Collin-Osdoby P. and Osdoby P. (1999) Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells. J. Clin. Invest. 103: 1409-1418
81. Panina-Bordignon P., Mazzeo D., Lucia P. D., D'Ambrosio D., Lang R., Fabbri L. et al. (1997) Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 100: 1513-1519